Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
158 employees · est. 2019 · San Mateo, United States
iktos is the older company (2019 vs 2016).
Side-by-Side Comparison
| Metric | Genesis Molecular AI | iktos |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2016 older |
| Headquarters | ||
| Headquarters | San Mateo, United States | Paris, France |
| Employees | ||
| Employees | 158 | 85 |
| Industry | ||
| Industry | AI, Biotechnology, Information Technology | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Unknown | Series A |
| Total Funding | ||
| Total Funding | $280.13M | $18.90M |
| Funding Rounds | ||
| Funding Rounds | 5 | 7 |
| Services | ||
| Services | AI Research and Development, Molecular Design Platforms, Drug Discovery Solutions, AI Model Capabilities Enhancement | Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Drug Development Teams | Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams |
| Taxonomy | ||
| Taxonomy | Molecular AI, Drug Discovery, Generative AI, Predictive AI, GEMS Platform, Small Molecule Drugs, Structure Prediction, AI-Enabled Discovery, Lead Optimization, Biophysics Simulation, Neural Networks, Computational Chemistry, Undruggable Targets, AI Collaborations, Pharmaceutical Innovation | Drug Design, Medicinal Chemistry, Generative AI, Chemoinformatics, Robotics Automation, SaaS Software, Molecular Modeling, Oncology, Retrosynthesis, Protein-Protein Interactions, RNA-Protein Interactions, Synthesis Automation, Pharmaceutical R&D, Lead Optimization |
| Website | ||
| Website | genesistherapeutics.ai | iktos.ai |
About Genesis Molecular AI
Genesis Molecular AI, founded in 2019 and headquartered in the United States, is at the forefront of merging AI and Biotechnology to enhance drug discovery processes. With an innovative slogan, “Unifying AI and Biotech to accelerate the discovery of new medicines,” the company is redefining drug des...
About iktos
Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's...
We will tell you when either one moves
BounceWatch watches Genesis Molecular AI and iktos for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Genesis Molecular AI and iktos — by email.
Frequently Asked Questions
Compare Genesis Molecular AI with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Genesis Molecular AI on 18 Sep 2026, and iktos on 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.